Letters
Drug eluting stents
What fuels public policy?
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39150.648762.BE (Published 22 March 2007) Cite this as: BMJ 2007;334:599
This article has a correction. Please see:
- Mark H Wilson, director of medical ethics health (research@sympatico.ca)
- Health Research Associates, Ottawa, Canada K2B 6J4
Around 60-75% of the millions of drug eluting stents inserted globally are not licensed.1 What has fuelled the high unlicensed use of a device associated with thrombosis? This question was not dealt with by the Food and Drug Administration panel or recent articles on such stents.2 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.